Oncology

Real-World Perspectives on ctDNA Applications in Breast Cancer Management: Oranus Mohammadi, MD

Integrating ctDNA Into Breast Cancer Management: Joanne Mortimer, MD, FACP, FASCO

Addressing Learning Curves in Rare NSCLC Subtypes and Targeted Therapy Use: Jorge Nieva, MD

Overcoming Barriers to Molecular Testing in NSCLC Care: Jorge Nieva, MD

Addressing Social Determinants of Health Through Value-Based Oncology Care: Yale Podnos, MD, MPH, FACS

Improving Clinical Trial Diversity Through Language-Inclusive Approaches: Daniel Virnich, MD

Clinical Considerations for Immunotherapy Sequencing in NSCLC: Lauren Antrim, MD

Balancing Safety, Cost, and Duration in Immunotherapy for NSCLC: Lauren Antrim, MD

Addressing Financial and Socioeconomic Barriers to Precision NSCLC Care: Jonathan Thompson, MD, MS

Insurance Delays Add Costs to CAR T-Cell Therapy: Ravi Vij, MD, MBA

Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD

Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions

Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic

Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman

Oncology Onward: A Conversation With OneOncology’s Dr Jeff Patton

Health Equity Conversations: Improving Diversity of Oncology Care Staff

Lymphoma Research Foundation CEO on Biden’s Cancer Moonshot, Financial Toxicity

Reforming Oncology Care Payments: Interviews From the QCCA Leadership Summit

What Are the Next Steps for Collaboration, Accountability in Oncology Care First?

KOL Corner: Amy Ellis Discusses Value-Based Cancer Rehab With Amanda Hodges